bioAffinity Technologies (BIAF) Ownership - Who owns bioAffinity Technologies?
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BIAF showed earnings on May 15, 2025. You can read more about the earnings report here.